NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
National Institutes of Health · Chronic Diseases: Research, Control, and Prevention (93.068)
Posted 28 May 2026 · About 6 months left
In plain terms
The US National Institutes of Health funds small US businesses to develop and commercialise health-related scientific innovations through feasibility studies and research and development projects. Applications are open from 28 May 2026 and must be submitted by 5 April 2027.
A generated summary of the donor's text; the original wording is below.
Summary
The Small Business Innovation Research (SBIR) program helps United States small business concerns (SBCs) bring scientific innovations to the marketplace. The SBIR program supports feasibility studies to later research and development (R&D) needed to develop a commercial product.
Excerpt from the donor's page. The full text, annexes and forms are on the original call.
Who can apply
- private_company
Eligibility and conditions
Show the eligibility text from the source
Applicant types: Small businesses
Only United States small business concerns (SBCs), as defined by the Small Business Administration (SBA)(sbir.gov/apply) are eligible to submit applications for this opportunity.Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Unfunded international collaborations or unfunded foreign components, as defined in the NIH Grants Policy Statement, may be allowed.